Index -
P/E 15.39
EPS (ttm) 0.68
Insider Own 0.94%
Shs Outstand 494.45M
Perf Week -3.73%
Market Cap 5.17B
Forward P/E 10.78
EPS next Y 0.97
Insider Trans 0.98%
Shs Float 489.95M
Perf Month -9.02%
Income 338.00M
PEG 2.34
EPS next Q 0.31
Inst Own 100.15%
Short Float 2.95%
Perf Quarter -16.44%
Sales 4.44B
P/S 1.16
EPS this Y -8.48%
Inst Trans 1.47%
Short Ratio 3.08
Perf Half Y -29.33%
Book/sh 12.33
P/B 0.85
EPS next Y 16.38%
ROA 2.51%
Short Interest 14.46M
Perf Year -36.50%
Cash/sh 0.95
P/C 11.04
EPS next 5Y 6.57%
ROE 5.49%
52W Range 10.03 - 18.80
Perf YTD -13.75%
Dividend Est. -
P/FCF 13.11
EPS past 5Y 29.95%
ROI 3.23%
52W High -44.44%
Beta 1.45
Dividend TTM -
Quick Ratio 1.25
Sales past 5Y 9.07%
Gross Margin 43.01%
52W Low 4.14%
ATR (14) 0.45
Dividend Ex-Date -
Current Ratio 2.44
EPS Y/Y TTM 127.38%
Oper. Margin 5.65%
RSI (14) 39.92
Volatility 3.74% 3.98%
Employees 9450
Debt/Eq 0.73
Sales Y/Y TTM 0.50%
Profit Margin 7.61%
Recom 1.88
Target Price 15.67
Option/Short Yes / Yes
LT Debt/Eq 0.72
EPS Q/Q 94.34%
Payout 0.00%
Rel Volume 0.75
Prev Close 10.04
Sales Surprise 1.10%
EPS Surprise -6.04%
Sales Q/Q -1.45%
Earnings Feb 25 BMO
Avg Volume 4.70M
Price 10.44
SMA20 -5.15%
SMA50 -9.52%
SMA200 -22.92%
Trades
Volume 3,332,672
Change 4.03%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-09-24 Initiated
UBS
Buy
$18
Dec-02-24 Initiated
Leerink Partners
Market Perform
$14
Sep-19-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$17 → $15
Jan-05-24 Upgrade
Stifel
Hold → Buy
$13 → $20
Dec-19-23 Initiated
Jefferies
Buy
$17
Dec-15-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$16
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$18
Apr-20-23 Upgrade
Barclays
Equal Weight → Overweight
$14
Aug-18-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$37 → $22
Aug-16-22 Downgrade
JP Morgan
Overweight → Neutral
$28 → $24
Jul-21-22 Downgrade
Goldman
Buy → Sell
$32 → $19
Jul-12-22 Initiated
Piper Sandler
Neutral
$22
Nov-18-21 Initiated
Morgan Stanley
Overweight
$40
Oct-28-21 Downgrade
Stifel
Buy → Hold
$37 → $34
Aug-05-21 Resumed
Credit Suisse
Outperform
$38
Jun-15-21 Upgrade
Cleveland Research
Underperform → Neutral
May-11-21 Upgrade
Gabelli & Co
Hold → Buy
May-11-21 Upgrade
Barclays
Underweight → Equal Weight
$25 → $29
Apr-15-21 Initiated
Stifel
Buy
$37
Mar-22-21 Downgrade
Gabelli & Co
Buy → Hold
Show Previous Ratings
Mar-11-25 11:05PM
Feb-26-25 06:09PM
02:05AM
12:34AM
(Thomson Reuters StreetEvents)
Feb-25-25 01:38PM
01:15PM
Loading…
01:15PM
09:30AM
08:20AM
07:15AM
07:05AM
07:05AM
Feb-24-25 09:16AM
08:05AM
Feb-21-25 08:00AM
Feb-20-25 12:05PM
08:27AM
Loading…
08:27AM
Feb-13-25 04:29PM
Feb-10-25 12:17PM
Feb-04-25 08:00AM
Feb-03-25 12:18AM
Jan-30-25 02:45PM
Jan-27-25 08:06AM
Jan-23-25 08:27AM
Jan-12-25 09:38AM
Jan-10-25 12:30PM
Dec-19-24 11:07AM
Dec-01-24 09:08AM
Nov-29-24 12:18PM
Nov-27-24 01:45PM
Nov-26-24 07:22AM
04:31AM
Loading…
04:31AM
Nov-25-24 08:45AM
08:00AM
Nov-24-24 11:33AM
Nov-23-24 07:23AM
Nov-21-24 10:46AM
Nov-20-24 08:53AM
Nov-18-24 02:52PM
Nov-15-24 11:30AM
Nov-14-24 03:15PM
Nov-13-24 01:39PM
Nov-12-24 07:20PM
(The Wall Street Journal)
08:33AM
05:45AM
Nov-11-24 04:02PM
Nov-08-24 04:03AM
02:09AM
02:03AM
(Thomson Reuters StreetEvents)
Nov-07-24 04:30PM
03:28PM
12:41PM
09:30AM
08:52AM
07:35AM
06:27AM
Nov-05-24 07:38AM
Nov-04-24 03:51PM
09:16AM
Nov-01-24 05:45AM
Oct-31-24 01:42PM
10:01AM
Oct-30-24 11:46AM
Oct-28-24 07:17PM
Oct-25-24 09:56AM
Oct-24-24 02:29PM
Oct-23-24 10:16AM
Oct-22-24 10:42AM
Oct-21-24 06:12PM
Oct-17-24 12:14PM
12:10PM
Oct-16-24 11:21AM
08:54AM
Oct-11-24 09:14AM
Oct-10-24 08:00AM
Oct-09-24 11:23AM
Oct-08-24 08:43PM
Oct-07-24 04:19PM
Sep-20-24 10:35AM
Sep-19-24 03:08PM
01:42PM
12:50PM
Sep-13-24 07:30AM
Aug-28-24 06:30AM
Aug-20-24 06:27AM
Aug-15-24 08:27AM
Aug-13-24 01:49PM
Aug-09-24 02:35AM
(Thomson Reuters StreetEvents)
Aug-08-24 03:45PM
09:30AM
07:35AM
06:28AM
Aug-06-24 01:00PM
Aug-05-24 09:16AM
Aug-01-24 03:14PM
10:01AM
Jul-30-24 08:27AM
Jul-25-24 01:18PM
Jul-22-24 02:42PM
10:18AM
Jul-18-24 08:00AM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kurzius Lawrence Erik Director Mar 07 '25 Buy 10.90 10,000 109,000 101,459 Mar 11 05:13 PM Kurzius Lawrence Erik Director Mar 11 '25 Buy 10.20 10,000 102,000 111,459 Mar 11 05:13 PM HOOVER R DAVID Director Mar 05 '25 Buy 10.90 25,000 272,558 210,000 Mar 07 04:21 PM Harrington Michael J Director Aug 22 '24 Buy 14.85 3,500 51,974 81,094 Aug 26 05:05 PM Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Aug 12 '24 Buy 13.01 100,000 1,300,610 145,000 Aug 13 09:04 AM DOYLE WILLIAM F Director May 21 '24 Buy 16.98 15,000 254,700 76,330 May 23 04:33 PM
Index S&P 500
P/E 27.93
EPS (ttm) 2.92
Insider Own 6.02%
Shs Outstand 252.30M
Perf Week -1.30%
Market Cap 21.90B
Forward P/E 24.57
EPS next Y 3.32
Insider Trans -0.60%
Shs Float 252.00M
Perf Month 6.50%
Income 788.50M
PEG 4.02
EPS next Q 0.64
Inst Own 82.23%
Short Float 2.61%
Perf Quarter 5.36%
Sales 6.72B
P/S 3.26
EPS this Y 3.95%
Inst Trans 2.77%
Short Ratio 3.25
Perf Half Y -1.91%
Book/sh 19.74
P/B 4.14
EPS next Y 8.35%
ROA 6.08%
Short Interest 6.57M
Perf Year 19.06%
Cash/sh 0.69
P/C 117.70
EPS next 5Y 6.94%
ROE 15.23%
52W Range 66.88 - 86.24
Perf YTD 7.10%
Dividend Est. 1.81 (2.22%)
P/FCF 33.86
EPS past 5Y 2.22%
ROI 8.71%
52W High -5.32%
Beta 0.74
Dividend TTM 1.71 (2.09%)
Quick Ratio 0.31
Sales past 5Y 4.78%
Gross Margin 38.51%
52W Low 22.08%
ATR (14) 2.13
Dividend Ex-Date Dec 30, 2024
Current Ratio 0.74
EPS Y/Y TTM 15.79%
Oper. Margin 15.89%
RSI (14) 53.89
Volatility 2.71% 2.64%
Employees 14100
Debt/Eq 0.86
Sales Y/Y TTM 0.92%
Profit Margin 11.73%
Recom 2.50
Target Price 85.75
Option/Short Yes / Yes
LT Debt/Eq 0.71
EPS Q/Q -1.91%
Payout 57.44%
Rel Volume 0.74
Prev Close 83.18
Sales Surprise 1.42%
EPS Surprise 4.07%
Sales Q/Q 2.58%
Earnings Mar 25 BMO
Avg Volume 2.02M
Price 81.65
SMA20 0.99%
SMA50 5.28%
SMA200 6.00%
Trades
Volume 1,430,789
Change -1.84%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-08-25 Upgrade
TD Cowen
Hold → Buy
$86 → $90
Dec-09-24 Upgrade
Jefferies
Hold → Buy
$85 → $91
Jun-12-24 Upgrade
Citigroup
Sell → Neutral
$68 → $69
Apr-02-24 Upgrade
Argus
Hold → Buy
Feb-01-24 Initiated
Citigroup
Sell
$60
Jan-22-24 Downgrade
Consumer Edge Research
Overweight → Equal Weight
Sep-22-23 Initiated
HSBC Securities
Hold
$86
Sep-13-23 Initiated
TD Cowen
Market Perform
$87
Jun-06-23 Upgrade
BofA Securities
Underperform → Buy
$75 → $100
Apr-14-23 Resumed
Stifel
Hold
$82
Mar-10-23 Initiated
UBS
Sell
$71
Jan-27-23 Upgrade
Bernstein
Mkt Perform → Outperform
$90
Nov-15-22 Initiated
Exane BNP Paribas
Outperform
$94
Jul-06-22 Downgrade
Argus
Buy → Hold
Feb-17-22 Upgrade
Argus
Hold → Buy
$112
Jan-19-22 Downgrade
Credit Suisse
Outperform → Neutral
$100
Mar-17-21 Downgrade
Argus
Buy → Hold
Sep-24-20 Initiated
Argus
Buy
$215
Jun-22-20 Upgrade
Jefferies
Underperform → Hold
$167
May-14-20 Upgrade
Credit Suisse
Neutral → Outperform
$147 → $187
Show Previous Ratings
Mar-11-25 06:38PM
Mar-02-25 10:24AM
Feb-26-25 08:55AM
Feb-04-25 03:15PM
Jan-28-25 04:30PM
07:25PM
Loading…
Jan-27-25 07:25PM
Jan-23-25 10:37AM
06:30AM
Jan-10-25 07:23PM
Jan-02-25 04:30PM
04:30PM
Nov-25-24 08:15AM
08:15AM
Nov-19-24 05:15PM
Oct-27-24 08:30AM
08:30AM
Loading…
Oct-24-24 08:30AM
Oct-23-24 02:04PM
08:24AM
Oct-22-24 06:29PM
05:46PM
Oct-17-24 04:30PM
Oct-08-24 02:27PM
Oct-01-24 01:09PM
01:04PM
11:59AM
06:30AM
Sep-30-24 05:03PM
Sep-24-24 04:35PM
Sep-16-24 07:02PM
Aug-29-24 04:30PM
04:30PM
Loading…
Aug-15-24 04:30PM
Aug-14-24 04:53PM
Jul-26-24 07:15PM
Jul-16-24 10:43AM
Jul-01-24 06:16AM
Jun-28-24 09:14AM
08:03AM
Jun-27-24 05:08PM
04:49PM
02:02PM
12:50PM
12:13PM
11:00AM
10:52AM
09:48AM
(The Wall Street Journal)
09:30AM
07:40AM
06:45AM
06:30AM
Jun-26-24 05:06PM
04:56PM
12:58PM
Jun-25-24 04:50PM
Jun-24-24 09:15AM
Jun-21-24 09:00AM
Jun-20-24 10:00AM
Jun-19-24 11:44AM
Jun-18-24 11:56AM
Jun-10-24 05:33AM
Jun-05-24 10:05AM
May-30-24 08:00AM
May-29-24 05:30AM
(The Wall Street Journal)
May-28-24 07:41PM
May-22-24 06:15AM
May-21-24 05:10PM
May-20-24 06:15AM
May-17-24 08:00AM
May-15-24 10:35AM
May-14-24 04:50PM
May-06-24 02:00PM
May-02-24 02:20PM
Apr-30-24 03:32PM
02:48PM
Apr-25-24 11:30AM
Apr-22-24 12:53PM
Apr-16-24 03:19AM
Apr-02-24 04:50PM
08:00AM
Mar-28-24 01:54PM
Mar-27-24 04:40PM
12:54PM
Mar-26-24 05:11PM
01:23PM
12:50PM
(The Wall Street Journal)
11:05AM
(The Wall Street Journal)
10:53AM
10:17AM
10:07AM
09:32AM
07:03AM
(The Wall Street Journal)
06:30AM
Mar-25-24 05:11PM
Mar-24-24 10:58AM
07:56AM
Mar-22-24 04:31PM
Mar-21-24 12:28PM
Mar-19-24 10:00AM
Mar-14-24 06:05AM
Feb-29-24 08:00AM
Feb-28-24 03:40PM
McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PRESTON MARGARET M V Director Feb 13 '25 Sale 77.03 28,092 2,163,927 6,177 Feb 14 10:12 AM Tapiero Jacques Director Feb 03 '25 Option Exercise 78.03 707 55,163 29,102 Feb 04 03:30 PM Kurzius Lawrence Erik Director Feb 03 '25 Option Exercise 49.96 50,000 2,498,000 326,895 Feb 04 03:15 PM Kurzius Lawrence Erik Director Feb 03 '25 Sale 76.81 50,000 3,840,320 276,895 Feb 04 03:15 PM Tapiero Jacques Director Nov 11 '24 Option Exercise 38.15 5,000 190,725 33,217 Nov 12 12:58 PM Tapiero Jacques Director Nov 11 '24 Sale 77.34 5,000 386,702 28,217 Nov 12 12:58 PM MANGAN MICHAEL D Director Nov 06 '24 Option Exercise 38.15 5,000 190,725 45,436 Nov 08 08:35 AM MANGAN MICHAEL D Director Nov 06 '24 Sale 79.00 5,000 395,000 40,436 Nov 08 08:35 AM Tapiero Jacques Director Nov 04 '24 Option Exercise 38.15 5,000 190,725 33,217 Nov 05 10:59 AM Tapiero Jacques Director Nov 04 '24 Sale 78.33 5,000 391,672 28,217 Nov 05 10:59 AM MANGAN MICHAEL D Director Nov 01 '24 Option Exercise 38.15 5,000 190,725 45,436 Nov 04 12:50 PM MANGAN MICHAEL D Director Nov 01 '24 Sale 78.50 5,000 392,500 40,436 Nov 04 12:50 PM Montiel Maritza Gomez Director Aug 15 '24 Option Exercise 49.31 9,816 484,034 12,410 Aug 15 04:45 PM Montiel Maritza Gomez Director Aug 15 '24 Sale 76.84 9,816 754,307 5,594 Aug 15 04:45 PM Kurzius Lawrence Erik Director Jul 17 '24 Sale 75.00 25,000 1,875,000 0 Jul 17 01:27 PM Kurzius Lawrence Erik Director May 21 '24 Option Exercise 38.15 80,000 3,051,600 279,258 May 22 12:02 PM Kurzius Lawrence Erik Director May 21 '24 Sale 73.75 80,000 5,900,024 199,258 May 22 12:02 PM Jenkins Katherine Chief Growth Officer May 14 '24 Sale 75.91 2,732 207,390 0 May 14 04:53 PM Jenkins Katherine Chief Growth Officer Apr 22 '24 Sale 74.35 1,726 128,326 0 Apr 23 05:15 PM LITTLE PATRICIA A Director Apr 01 '24 Option Exercise 44.05 20,000 881,050 34,732 Apr 02 01:18 PM LITTLE PATRICIA A Director Apr 01 '24 Sale 75.57 20,000 1,511,445 24,732 Apr 02 01:18 PM Montiel Maritza Gomez Director Mar 28 '24 Option Exercise 49.96 7,000 349,720 12,594 Mar 29 12:12 PM Montiel Maritza Gomez Director Mar 28 '24 Sale 77.00 7,000 538,986 5,594 Mar 29 12:12 PM PRESTON MARGARET M V Director Mar 15 '24 Option Exercise 0.00 1,255 0 98,864 Mar 19 03:49 PM BRAMMAN ANNE L Director Mar 15 '24 Option Exercise 0.00 1,255 0 5,239 Mar 19 03:39 PM HRABOWSKI FREEMAN A III Director Mar 15 '24 Option Exercise 0.00 1,255 0 102,456 Mar 19 02:56 PM Montiel Maritza Gomez Director Mar 15 '24 Option Exercise 0.00 1,255 0 5,594 Mar 19 02:54 PM LITTLE PATRICIA A Director Mar 15 '24 Option Exercise 0.00 1,255 0 24,732 Mar 19 02:52 PM Jenkins Katherine Chief Growth Officer Mar 15 '24 Option Exercise 0.00 802 0 3,383 Mar 19 02:28 PM Foust Andrew President, Americas Mar 15 '24 Option Exercise 0.00 1,239 0 5,406 Mar 19 02:25 PM Piper Sarah Chief Human Relations Officer Mar 15 '24 Option Exercise 0.00 367 0 2,177 Mar 19 02:22 PM Sanchez Ana President EMEA Mar 15 '24 Option Exercise 0.00 801 0 3,818 Mar 19 02:20 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite